NovaBridge Biosciences (NBP) Debt Ratio (2018 - 2023)

NovaBridge Biosciences (NBP) has reported Debt Ratio for 4 consecutive years, with 0.01 the latest figure, recorded in Q4 2023.

• Quarterly Debt Ratio rose 146.49% year-over-year to 0.01 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.01 (up 146.49% YoY) and the FY2023 annual result came in at 0.01, up 146.93% from the prior year.
• Debt Ratio improved to 0.01 in Q4 2023 per NBP's latest filing, from 0.01 in the prior quarter.
• Over the last five years, Debt Ratio for NBP reached as high as 0.03 in Q4 2019 and fell as low as 0.0 in Q4 2022.
• A 3-year average of 0.01 and a median of 0.01 in 2023 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2019 — Debt Ratio fell 14.54% — and 2023, when it soared 146.49%.
• Year by year, Debt Ratio stood at 0.03 in 2019, then plunged by 83.83% to 0.0 in 2022, then surged by 146.49% to 0.01 in 2023.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.01, 0.01, and 0.0 for Q4 2023, Q2 2023, and Q4 2022 respectively.